Maternal Immunization with Adjuvanted Recombinant Receptor-Binding Domain Protein Provides Immune Protection against SARS-CoV-2 in Infant Monkeys
Open Access
Abstract
Maternal vaccinations administered prior to conception or during pregnancy enhance the immune protection of newborn infants against many pathogens. A feasibility experiment was conducted to determine if monkeys can be used to model the placental transfer of maternal antibody against SARS-CoV-2. Six adult rhesus monkeys were immunized with adjuvanted recombinant-protein antigens comprised of receptor-binding domain human IgG1-Fc fusion proteins (RBD-Fc) containing protein sequences from the ancestral-Wuhan or Gamma variants. The female monkeys mounted robust and sustained anti-SARS-CoV-2 antibody responses. Blood samples collected from their infants after delivery verified prenatal transfer of high levels of spike-specific IgG, which were positively correlated with maternal IgG titers at term. In addition, an in vitro test of ACE2 neutralization indicated that the infants’ IgG demonstrated antigen specificity, reflecting prior maternal immunization with either Wuhan or Gamma-variant antigens. All sera showed stronger ACE2-RBD binding inhibition when variants in the assay more closely resembled the vaccine RBD sequence than with more distantly related variants (i.e., Delta and Omicron). Monkeys are a valuable animal model for evaluating new vaccines that can promote maternal and infant health. Further, the findings highlight the enduring nature and safety of the immune protection elicited by an adjuvanted recombinant RBD-Fc vaccine.Keywords
Funding Information
- University of Wisconsin-Madison
This publication has 75 references indexed in Scilit:
- Maternal Pertussis Immunization and Immunoglobulin G Levels in Early- to Late-Term and Preterm InfantsJAMA Network Open, 2024
- Neonatal Outcomes After COVID-19 Vaccination in PregnancyJAMA, 2024
- Timing of Maternal COVID-19 Vaccine and Antibody Concentrations in Infants Born PretermJAMA Network Open, 2024
- mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among InfantsJAMA Network Open, 2023
- Assessment of Adverse Reactions, Antibody Patterns, and 12-month Outcomes in the Mother-Infant Dyad After COVID-19 mRNA Vaccination in PregnancyJAMA Network Open, 2023
- Sex-Specific Neurodevelopmental Outcomes Among Offspring of Mothers With SARS-CoV-2 Infection During PregnancyJAMA Network Open, 2023
- Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 InfectionJAMA Network Open, 2022
- Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United StatesJAMA Network Open, 2022
- Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in InfantsJAMA Internal Medicine, 2022
- Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 PandemicJAMA Network Open, 2020